Global rise of large food chains linked to obesity epidemic; unhealthy food sales spike dramatically over last decade.
Risk Adjusted Net Present Value: What is the current valuation of SQZ Biotechnologies’s SQZ-AAC- HPV
The revenue for SQZ-AAC- HPV is expected to reach an annual total of $88 mn by 2038 in the US based off GlobalData’s Expiry Model.